Danaher DHR
NYSE DHR
$215.73 +0.37 (+0.17%)
As of: Aug 27, 2026 · 3:59 PM EDT

Danaher (DHR) Non Operating Investment Income (2013)

Danaher (DHR) posted quarterly Non Operating Investment Income of $229.8 million for Q1 2013.

Danaher (DHR) Non Operating Investment Income (2013) Analysis & Trends

Danaher's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at $229.8 million for Q1 2013.

  • In Q1 2013, Non Operating Investment Income changed N/A year-over-year to $229.8 million; the TTM figure through Dec 2013 stood at $229.8 million (changed N/A YoY), while the FY2013 annual figure was $229.8 million, changed N/A from the prior year.
  • Non Operating Investment Income for Q1 2013 stood at $229.8 million.
  • The five-year high for Non Operating Investment Income was $229.8 million in Q1 2013, with the low at $229.8 million in Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2013 229.80 Mn
Mar 29, 2013 229.80 Mn